Investigation of Cytotoxicity and Lipid-lowering Effects of Rivea hypocrateriformis Desr. Leaf Extracts on HepG2 Cells: An in vitro Study

Bai, Helen Sheeba Devadhasan Aspathi and Rethnaswamy, Gandhimathi (2025) Investigation of Cytotoxicity and Lipid-lowering Effects of Rivea hypocrateriformis Desr. Leaf Extracts on HepG2 Cells: An in vitro Study. Pharmacognosy Magazine, 21 (1). pp. 229-242. ISSN 0973-1296

[thumbnail of bai-rethnaswamy-2024-investigation-of-cytotoxicity-and-lipid-lowering-effects-of-rivea-hypocrateriformis-desr-leaf.pdf] Text
bai-rethnaswamy-2024-investigation-of-cytotoxicity-and-lipid-lowering-effects-of-rivea-hypocrateriformis-desr-leaf.pdf

Download (5MB)

Abstract

Investigation of Cytotoxicity and Lipid-lowering Effects of Rivea hypocrateriformis Desr. Leaf Extracts on HepG2 Cells: An in vitro Study Helen Sheeba Devadhasan Aspathi Bai School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamil Nadu, India https://orcid.org/0009-0009-7835-0477 Gandhimathi Rethnaswamy Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamil Nadu, India Background and Purpose

Chronic diseases, such as cardiovascular disease as well as type 2 diabetes, are associated with hyperlipidemia, characterized by high blood lipid levels. HepG2 cells, a human liver cancer cell line, have become a popular model for evaluating the effectiveness of drugs in treating hyperlipidemia. These cells are preferred due to their ability to mimic liver cell physiology and easy maintenance in culture.
Materials and Methods

In this study, HEP, HEC, HEA, and HEE extracts of Rivea hypocrateriformis were tested on HepG2 cells for cytotoxicity using the MTT assay. The IC 50 values of the extracts were determined and compared to analyze their toxicity. Microscopic images of the cell lines were also examined to observe any structural changes induced by the extracts.
Results and Conclusion

The results showed that both HEC and HEE extracts exhibited significant toxicity on HepG2 cells at the highest concentration of 500 µg/ml. Gradual decreases in concentration led to a gradual rise in % cell viability. The IC 50 values of HEC and HEE were calculated to be 61.49 µg/ml and 87.08 µg/ml, respectively, indicating that HEC was slightly more toxic than HEE. According to the results obtained using the vanilla method, HEC and HEE extracts markedly reduced lipid content compared to the oleic acid-induced group. The gene expression regulation of AMPK, FAS, LDL receptor, and HMG-CoA was investigated using the RT-PCR method. The results showed that the extract-treated groups exhibited higher AMPK and LDL receptor gene expression. In contrast, the HEE extract showed higher activity than HEC in suppressing the FAS gene. Overall, the findings suggest that HEC and HEE extracts have potential as anticancer and lipid-lowering agents. Detailed research is needed to understand how the active constituents work.
08 26 2024 03 2025 229 242 10.1177/09731296241263660 https://creativecommons.org/licenses/by-nc/4.0/ 10.1177/09731296241263660 https://journals.sagepub.com/doi/10.1177/09731296241263660 http://sage.cnpereading.com/paragraph/article/?doi=10.1177/09731296241263660 https://journals.sagepub.com/doi/pdf/10.1177/09731296241263660 https://journals.sagepub.com/doi/pdf/10.1177/09731296241263660 https://journals.sagepub.com/doi/full-xml/10.1177/09731296241263660 10.1016/j.jksus.2022.102256 10.1155/2012/970635 10.4103/0974-8520.182755 10.3389/fnut.2021.775382 10.1007/s10600-018-2277-3 10.1038/s41598-018-27420-2 10.1182/blood.V52.6.1099.1099 Médecine Therapeutique Khan A. A. 1 19 1 2019 10.1038/emm.2016.16 Kim J., Yang G., Kim Y., Kim J. & Ha J. (2016). AMPK activators: Mechanisms of action and physiological activities. 10.2337/db06-0006 10.3389/fphar.2022.857956 10.1007/s10068-010-0179-7 10.3390/foods8060185 10.1186/s12906-020-03162-5 10.1177/2053951716666102 Plant Growth Regulation Marshall N. J. 69 5 2 1995 10.1016/0022-1759(83)90303-4 10.1155/2022/9099672 Pharmaceutical Sciences and Research Patel V. B. 85 1 12 2010 10.1007/s10482-015-0524-1 Current Bioactive Compounds Rotimi D. 21 18 5 2022 10.3748/wjg.v20.i9.2279 10.1016/S2213-8587(19)30388-2 10.1021/jf900730e 10.1074/jbc.M408149200

Item Type: Article
Subjects: Pharmacology > Drug Relations
Domains: Pharmacology
Depositing User: Mr IR Admin
Date Deposited: 28 Aug 2025 07:29
Last Modified: 28 Aug 2025 07:29
URI: https://ir.vistas.ac.in/id/eprint/10660

Actions (login required)

View Item
View Item